tert-Butyl 2-cyanopiperazine-1-carboxylate, 95.0%, 25g

(2E)-3-(2,4-dimethoxyphenyl)-1-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

6-METHOXYIMIDAZO[1,2-B]PYRIDAZINE-2-CARBOXYLIC ACID, 95.0%, 250mg

2-Bromo-4-methylbenzaldehyde, 95.0%, 500g

Di-potassium hydrogen phosphate, min. 98%, Ph.Eur., anhydrous, 5 kg, plastic packaging.

5-Ethyl-2-methylaniline, 97%, 250mg

(4-(tert-Butylcarbamoyl)phenyl)boronic acid, 98%, 10g

Microliter syringe GASTIGHT® series 1700 Point type 3, 10 µl, 1701 RNR, 1 piece

3-(Trifluoromethyl)benzophenone, 98.0%, 100g

4-Methyl-1-pentene>97.0%(GC)25mL

2-[3-(Trifluoromethyl)phenyl]cyclopropane-1-carboxylic acid, 95.0%, 1g

6-CHLORO-3-IODOIMIDAZO[1,2-A]PYRAZINE, 95.0%, 1g

1,8-Dibromooctane>97.0%(GC)100g